Celldex Therapeutics (CLDX) Receivables - Net (2016 - 2025)
Historic Receivables - Net for Celldex Therapeutics (CLDX) over the last 16 years, with Q3 2025 value amounting to $90000.0.
- Celldex Therapeutics' Receivables - Net fell 8943.66% to $90000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $90000.0, marking a year-over-year decrease of 8943.66%. This contributed to the annual value of $700000.0 for FY2024, which is 7336.38% down from last year.
- Latest data reveals that Celldex Therapeutics reported Receivables - Net of $90000.0 as of Q3 2025, which was down 8943.66% from $90000.0 recorded in Q2 2025.
- In the past 5 years, Celldex Therapeutics' Receivables - Net ranged from a high of $2.7 million in Q1 2024 and a low of $90000.0 during Q2 2025
- Over the past 5 years, Celldex Therapeutics' median Receivables - Net value was $347000.0 (recorded in 2022), while the average stood at $783263.2.
- In the last 5 years, Celldex Therapeutics' Receivables - Net surged by 120000.0% in 2024 and then crashed by 9413.3% in 2025.
- Over the past 5 years, Celldex Therapeutics' Receivables - Net (Quarter) stood at $172000.0 in 2021, then skyrocketed by 101.74% to $347000.0 in 2022, then surged by 657.35% to $2.6 million in 2023, then tumbled by 73.36% to $700000.0 in 2024, then plummeted by 87.14% to $90000.0 in 2025.
- Its Receivables - Net stands at $90000.0 for Q3 2025, versus $90000.0 for Q2 2025 and $1.1 million for Q1 2025.